The clinical significance of sarcopenia in patients with hepatocellular carcinoma treated with lenvatinib and PD-1 inhibitors

• DOI: 10.3389/fimmu.2024.1380477
• Publication Date: 2024-04-18T04:46:51Z
• Authors: Wei Sun; Xue Yin; Xiaomin Liu; Jianying Wei; Minghua Yu; Wendong Li; Xiaoyan Ding; Jinglong Chen
• Keywords: Lenvatinib; Cabozantinib; Clinical Significance

Sarcopenia has gained considerable attention in the context of hepatocellular carcinoma, as it been correlated with a poorer prognosis among patients undergoing sorafenib or lenvatinib treatment for carcinoma (HCC). The clinical significance sarcopenia first-line advanced HCC treated and programmed death-1 (PD-1) inhibitors needs to be clarified.